Investing.com - Chemed (NYSE: CHE) reported third quarter EPS of $5.64, $0.12 worse than the analyst estimate of $5.76. Revenue for the quarter came in at $606.2M versus the consensus estimate of $608.25M.
Guidance
Chemed sees FY 2024 EPS of $23.00-$23.15 versus the analyst consensus of $23.56.
Chemed's stock price closed at $609.80. It is up 3.23% in the last 3 months and up 8.46% in the last 12 months.
Chemed saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Chemed's stock price’s past reactions to earnings here.
According to InvestingPro, Chemed's Financial Health score is "great performance".
Check out Chemed's recent earnings performance, and Chemed's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar